LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT

被引：20
|
作者：
Chan, Mico [1 ]
Hsiao, Edward [1 ]
Turner, Jennifer [2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Nucl Med, Reserve Rd, St Leonards, NSW 2065, Australia
[2] Douglass Hanly Moir Pathol, Dept Histopathol, Sydney, NSW, Australia
[3] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2017年 / 42卷 / 03期
关键词：
Ga-68-PSMA PET/CT; brain metastases; prostate cancer; BRAIN METASTASIS; CARCINOMA;
D O I：
10.1097/RLU.0000000000001526
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Ga-68 prostate-specific membrane antigen PET/CT is increasingly used to evaluate extent of disease in prostate carcinoma. Parenchymal brain metastases originating from prostate cancer have highly variable imaging appearance. We present a 77-year-old man with cerebellar metastasis from prostate cancer showing focal uptake on prostate-specific membrane antigen PET/CT.
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [11] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 130 : 1 - 12
  • [12] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    CURRENT MEDICAL IMAGING, 2024, 20
  • [13] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [14] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [15] Diagnostic performance of 68Ga-PSMA PET/CT for restaging prostate cancer
    Hoffmann, Manuela
    Wieler, Helmut
    Maller-Habenthal, Jonas
    Trampert, Ludwin
    Miederer, Matthias
    Schreckenberger, Mathias
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [16] The Role of 68Ga-PSMA PET/CT Imaging in Intracranial Metastases
    Arslan, E.
    Ergul, N.
    Sahin, R.
    Karagoz, Y.
    Bozkaya, Y.
    Cermik, T. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S273 - S273
  • [17] 68Ga-PSMA PET/CT and Mesorectal Lymph Node Metastases
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (06) : 34N - 34N
  • [18] 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
    Peter Donato
    Andrew Morton
    John Yaxley
    Sachinka Ranasinghe
    Patrick E. Teloken
    Samuel Kyle
    Geoff Coughlin
    Rachel Esler
    Nigel Dunglison
    Robert A Gardiner
    Matthew J Roberts
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1843 - 1851
  • [19] 68Ga-PSMA PET/CT Images of Multiple Cutaneous Metastases in a Patient With Prostate Carcinoma
    Sivrikoz, Ilknur Ak
    Deveci, Hakan
    Ak, Ali Murat
    Acer, Ersoy
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 950 - 952
  • [20] 68Ga-PSMA PET/CT early detection of Prostate Cancer bone metastases: the end of the osteoblastic era?
    Artigas, C.
    Kamoun, T.
    Garcia, C.
    Wimana, Z.
    Ghanem, G.
    Van Velthoven, R.
    Otte, F.
    Gil, T.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S138 - S138
12345